Drug Trial Radar · NCT03832998
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
284
Actual
Start
Sep 5, 2019
Primary completion
Jan 8, 2025
Study completion Jan 7, 2026
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- Collaborators
- Novartis
- First posted
- Feb 6, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to \<12 years) and adolescents (12 to \<18 years) with chronic migraine. The study hypothesis is that in pediatric participants with chronic migraine, the combined erenumab dose group has a greater reduction from baseline to week 9 through week 12 (month 3) in monthly migraine days (MMDs) when compared with placebo in the double-blind treatment phase (DBTP).
Conditions
- Migraine
Interventions
Erenumab Dose 1Drug
Participants in the low body-weight group at day 1 and who are randomized to Dose Level 1 will receive this dose.
Erenumab Dose 2Drug
Participants in the low body-weight group at day 1 who are randomized to Dose Level 2 and participants in the high body-weight group at day 1 who are randomized to Dose Level 1 will receive this dose.
Erenumab Dose 3Drug
Participants in the high body-weight group at day 1 who are randomized to Dose Level 2 will receive this dose.
PlaceboOther
Placebo matching dose for erenumab dose 1, 2 and 3.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in MMD to Week 9 Through Week 12 (Month 3) of the DBTPTime frame: Baseline to Week 12
Locations
101 sites in 13 countries. Site status is shown where the registry gives one.
Paradigm Clinical Research Center Inc
San Diego, California
Childrens Hospital Colorado
Aurora, Colorado
Colorado Springs Neurological Associates
Colorado Springs, Colorado
New England Institute for Clinical Research
Stamford, Connecticut
Childrens National Health System
Washington D.C., District of Columbia
TrueBlue Clinical Research
Brandon, Florida
Northwest Florida Clinical Research Group Limited Liability Company
Gulf Breeze, Florida
Nicklaus Childrens Hospital
Miami, Florida
Pediatric Epilepsy and Neurology Specialists
Tampa, Florida
Premiere Research Institute
West Palm Beach, Florida
Rare Disease Research Center Pediatrics
Atlanta, Georgia
CenExel iResearch, LLC
Savannah, Georgia
Northwestern University
Chicago, Illinois
Chicago Headache Center and Research Institute
Chicago, Illinois
Josephson Wallack Munshower Neurology
Indianapolis, Indiana
University of Maryland, Baltimore
Baltimore, Maryland
New England Regional Headache Center Inc
Worcester, Massachusetts
Michigan Head Pain and Neurological Institute
Ann Arbor, Michigan
Clinical Research Institute Inc
Plymouth, Minnesota
Childrens Mercy Hospital and Clinics
Kansas City, Missouri
Mercy Research
St Louis, Missouri
Meridian Clinical Research LLC
Hastings, Nebraska
Dent Neurosciences Research Center
Amherst, New York
Modern Migraine MD
New York, New York
Columbia University Irving Medical Center
New York, New York
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio
Nationwide Childrens Hospital
Columbus, Ohio
Oregon Health and Science University
Portland, Oregon
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania
Preferred Primary Care Physicians, Inc
Pittsburgh, Pennsylvania
Palmetto Gastroenterology Clinical Research, LLC
Summerville, South Carolina
Child Neurology Consultants of Austin
Austin, Texas
Helios Clinical Research Inc
Burleson, Texas
Stryde Consulting LLC
Frisco, Texas
Childrens Specialty Group
Norfolk, Virginia
Vaught Neurological Services
Crab Orchard, West Virginia
Marshfield Clinic
Marshfield, Wisconsin
Universitair Ziekenhuis Brussel
Brussels, Belgium
Algemeen Ziekenhuis Sint-Maarten
Mechelen, Belgium
Showing 40 of 101 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.